https://www.indianpharmapost.com/cipla-posts-q4-fy24-consolidated-pat-at-rs-93904-cr-156272024-05-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-lal-pathlabs-posts-q4-fy24-consolidated-pat-at-rs-845-cr-156282024-05-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/hester-biosciences-posts-q4-fy24-consolidated-profit-increases-to-rs-495-cr-156292024-05-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/omron-healthcare-india-and-alivecor-partner-to-improve-heart-healthcare-in-india-156302024-05-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/strides-receives-usfda-approval-for-sevelamer-carbonate-tablets-156312024-05-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/ami-organics-posts-q4-fy24-consolidated-profit-at-rs-2514-cr-156322024-05-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/piramal-pharma-posts-q1-fy24-consolidated-pat-at-rs-10127-cr-156332024-05-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/neuland-laboratories-posts-q4-fy24-consolidated-pat-at-rs-6756-cr-156342024-05-11T00:00:00+05:30always0.9